MOTS-C 10mg Research Peptide - Precision Chain Peptides

MOTS-c (Mitochondrial ORF of the 12S rRNA Type-C) is a cutting-edge, 16-amino-acid mitochondrial-derived peptide (MDP) that plays a critical role in metabolic regulation, energy homeostasis, and cellular longevity. Discovered in 2015 by researchers at the University of Southern California (USC), it has quickly become a premier molecule of interest for researchers studying metabolic syndrome, athletic performance mimetics, and age-related physical decline.

Because your website sells research peptides, your content must strictly frame these benefits within an in vivo (animal model) and in vitro (cellular) research context, using authoritative scientific terminology to attract high-value researchers and biohackers looking for technical data.

 

• Mechanistic Profile: MOTS-c functions by disrupting the cellular folate-methionine cycle and inhibiting de novo purine biosynthesis.
• Research Impact: This intracellular shift increases endogenous levels of AICAR, which directly activates AMPK (AMP-activated protein kinase).
• Downstream Effects: Studies show this cascade switches cells from an anabolic (energy-storing) state to a catabolic (energy-burning) state, facilitating fatty acid β-oxidation.

---

• Glucose Transport: In animal models, MOTS-c promotes the translocation of GLUT4 glucose transporters into skeletal muscle tissue.
• Insulin Independence: This allows for cellular glucose uptake completely independent of insulin signaling pathways.
• Obesity Suppression: In pre-clinical trials published in journals like Cell Metabolism, mice fed a high-fat diet and treated with MOTS-c showed a 30% improvement in insulin sensitivity and were entirely resistant to diet-induced obesity and visceral fat accumulation.

---

• Performance Enhancements: Pre-clinical rodent models testing physical endurance demonstrated that a single dose of MOTS-c improved treadmill running performance by 12% to 15%. 
• Cardiovascular Markers: Ongoing research utilizing Seahorse metabolic flux assays notes that the peptide drastically improves the oxygen consumption rate (OCR) and spare respiratory capacity in muscle cells.
• Endogenous Levels: Studies published in Nature Communications show that natural MOTS-c levels spike nearly 12-fold in human skeletal muscle during physical exertion, establishing its role as an exercise-induced mitokine.

---

• Nuclear Translocation: Under metabolic stress, MOTS-c translocates directly to the cell nucleus to bind with adaptive response genes.
• Mitochondrial Biogenesis: It interacts with the PGC-1α pathway to stimulate the creation of new, healthy mitochondria, combating age-related mitochondrial dysfunction.
• Lifespan Extension: Chronic administration of MOTS-c in late-life mice (23.5 months old) reversed age-dependent insulin resistance and extended average lifespans while heavily improving overall healthspan indicators.

---

• Immune Modulation: Research proves that MOTS-c actively downregulates pro-inflammatory cytokines while increasing anti-inflammatory expressions like IL-10.
• Bone Density: In models studying osteoporosis, MOTS-c has been shown to improve bone metabolism by suppressing osteoclast differentiation via the OPG/RANKL pathway.
• Neuroprotection: Emerging literature highlights potential anti-inflammatory benefits that protect brain health and memory consolidation in neuro-degenerative models.